(Q36621361)

15 August 2017

Enhancement of the anti-tumour effect of cyclophosphamide by the bioreductive drugs AQ4N and tirapazamine (English)

1 reference

15 August 2017

7

Patterson LH

1 reference

15 August 2017

9

McKeown SR

1 reference

15 August 2017

Friery OP

1

1 reference

15 August 2017

Gallagher R

2

1 reference

15 August 2017

Murray MM

3

1 reference

15 August 2017

Hughes CM

4

1 reference

15 August 2017

Galligan ES

5

1 reference

15 August 2017

McIntyre IA

6

1 reference

15 August 2017

Hirst DG

8

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 April 2000

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

82

1 reference

15 August 2017

8

1 reference

15 August 2017

1469-1473

1 reference

https://scigraph.springernature.com/pub.10.1054/bjoc.1999.1132

15 August 2017

0 references

cites work

A direct measurement of the radiation sensitivity of normal mouse bone marrow cells

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363362

30 September 2017

https://api.crossref.org/works/10.1054%2FBJOC.1999.1132

DNA topoisomerase II-dependent cytotoxicity of alkylaminoanthraquinones and their N-oxides

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363362

The in situ tumour response to combinations of cyclophosphamide and tirapazamine.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363362

The experimental development of bioreductive drugs and their role in cancer therapy.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363362

Rationale for the use of aliphatic N-oxides of cytotoxic anthraquinones as prodrug DNA binding agents: a new class of bioreductive agent

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363362

Hypoxic cells as specific drug targets for chemotherapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363362

Potentiation by the hypoxic cytotoxin SR 4233 of cell killing produced by fractionated irradiation of mouse tumors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363362

Enhancement of alkylating agent activity by SR-4233 in the FSaIIC murine fibrosarcoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363362

Evidence for a therapeutic gain when AQ4N or tirapazamine is combined with radiation

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363362

Synergistic interaction between tirapazamine and cyclophosphamide in human breast cancer xenografts.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363362

AQ4N: an alkylaminoanthraquinone N-oxide showing bioreductive potential and positive interaction with radiation in vivo

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363362

The dynamics of tumor cords in an irradiated mouse mammary carcinoma with a large hypoxic cell component.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363362

Hypobaric hypoxia: A method for testing bioreductive drugs in vivo

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363362

Modification of the antitumor activity of chemotherapeutic drugs by the hypoxic cytotoxic agent tirapazamine

28 June 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10780528

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

In vitro cytotoxicity and chemosensitizing activity of the dual function nitroimidazole RB 6145

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10780528

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Bioreductive drugs as post-irradiation sensitizers: comparison of dual function agents with SR 4233 and the mitomycin C analogue EO9

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10780528

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1054/BJOC.1999.1132

1 reference

Dimensions Publication ID

15 August 2017

0 references

1 reference

15 August 2017

PubMed publication ID

10780528

1 reference